Hepatocellular Brg1 promotes CCl4-induced liver inflammation, ECM accumulation and fibrosis in mice
PLOS ONE · 30.11.2023 · 18 (11) · e0294257
DOI: 10.1371/journal.pone.0294257 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 30.11.2023. Verfasst von Baocai Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, TUM School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hepatitis, Liver Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wilhelm Sander-Stiftung.
Abstract (Originalsprache)
Introduction
Hepatic fibrosis is a progressive pathological process involving the exhaustion of hepatocellular regenerative capacity and ultimately leading to the development of cirrhosis and even hepatocellular carcinoma. Brg1, the core subunit of the SWI/SNF chromatin-remodeling complex, was recently identified as important for liver regeneration. This study investigates the role of Brg1 in hepatic fibrosis development.
Methods
Hepatocyte-specific Brg1 knockout mice were generated and injected with carbon tetrachloride (CCl 4 ) for 4, 6, 8, and 12 weeks to induce liver fibrosis. Afterwards, liver fibrosis and liver damage were assessed.
Results
Brg1 expression was significantly increased in the fibrotic liver tissue of wild-type mice, as compared to that of untreated wild-type mice. The livers of the Brg1 knockout animals showed reduced liver inflammation, extracellular matrix accumulation, and liver fibrosis. TNF-α and NF-κB-mediated inflammatory response was reduced in Brg1 knockout animals.
Conclusion
Brg1 promotes the progression of liver fibrosis in mice and may therefore be used as a potential therapeutic target for treating patients with liver fibrosis due to chronic injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery, TUM School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
- Department of General Surgery, The Affiliated Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.
- Institute of Pathology, TUM School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
- Department of Medicine II, TUM School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
ORCID-Profile: Daniel Hartmann
Förderung
- Wilhelm Sander-Stiftung
Zitieren
APA
Wang, B., Kaufmann, B., Mogler, C., Zhong, S., Yin, Y., Cheng, Z., Schmid, R. M., Friess, H., Hüser, N., von Figura, G., & Hartmann, D. (2023). Hepatocellular Brg1 promotes CCl4-induced liver inflammation, ECM accumulation and fibrosis in mice. PLOS ONE, 18(11), e0294257. https://doi.org/10.1371/journal.pone.0294257
Vancouver
Wang B, Kaufmann B, Mogler C, Zhong S, Yin Y, Cheng Z, et al. Hepatocellular Brg1 promotes CCl4-induced liver inflammation, ECM accumulation and fibrosis in mice. PLOS ONE. 2023;18(11):e0294257. doi:10.1371/journal.pone.0294257
BibTeX
@article{Wang2023,
author = {Wang, Baocai and Kaufmann, Benedikt and Mogler, Carolin and Zhong, Suyang and Yin, Yuhan and Cheng, Zhangjun and Schmid, Roland M and Friess, Helmut and Hüser, Norbert and von Figura, Guido and Hartmann, Daniel},
title = {Hepatocellular Brg1 promotes CCl4-induced liver inflammation, ECM accumulation and fibrosis in mice},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {11},
pages = {e0294257},
doi = {10.1371/journal.pone.0294257}
}
EUVIMED